Who owns the CTX310 trademark?

The CTX310 trademark is owned by CRISPR Therapeutics AG.

What is the serial number for CTX310?

The USPTO serial number for CTX310 is 97461217.

What is the registration number for CTX310?

CTX310 is registered under USPTO registration number 8005333.

CTX

USPTO Trademark Record

REGISTERED

CTX310

Q: What class is the CTX310 trademark registered in?

The CTX310 trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 97461217·Reg 8005333·Filed Jun 16, 2022

Owner CRISPR Therapeutics AG

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CTX310 (Serial No. 97461217), Registration No. 8005333, is a registered US trademark filed on Jun 16, 2022 by CRISPR Therapeutics AG. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: October 28, 2031

Mark Intelligence

CTX310 (Reg. #8005333) is a registered US trademark that has been protecting its owner, CRISPR Therapeutics AG, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 16, 2022

SERIAL

97461217

REG#

8005333

REGISTERED

Oct 28, 2025

Owner

Applicant

CRISPR Therapeutics AG

Entity

Not Provided

Address

Baarerstrasse 14, ZUG V8 SWITZERLAND, 6300

Country

Attorney

NameTiffany D. Gehrke

Law firm

Tiffany D. Gehrke MARSHALL, GERSTEIN & BORUN LLP

Docket

33324/60061

Address

233 SOUTH WACKER DRIVE, 6300 WILLIS TOWER, CHICAGO, IL 60606, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 16, 2022

Serial Number97461217

Registration No.8005333

Registration DateOct 28, 2025

Status DateOct 28, 2025

Published for OppositionApr 23, 2024

Mark TypeStandard characters

Attorney Docket33324/60061

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 17, 2023

First use in commerce: Nov 17, 2023

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Nov 17, 2023

First use in commerce: Nov 17, 2023

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

46 events

REGISTERED-PRINCIPAL REGISTER

Oct 28, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 28, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 09, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 09, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 16, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 16, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 10, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Jun 12, 2025

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Jun 12, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 12, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO LIE

May 15, 2025

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 15, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 15, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 30, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Feb 03, 2025

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Feb 03, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 03, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jan 13, 2025

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 11, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Oct 28, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Oct 28, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 18, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 23, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 23, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 03, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 16, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Feb 27, 2024

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 27, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 27, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Dec 18, 2023

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Dec 18, 2023

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

FINAL REFUSAL WRITTEN

Oct 02, 2023

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Oct 02, 2023

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Oct 02, 2023

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 11, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 10, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 10, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

ASSIGNED TO EXAMINER

Jul 03, 2023

ASSIGNED TO EXAMINER

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

May 11, 2023

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

May 11, 2023

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Feb 14, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 14, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 14, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 07, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 30, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 20, 2022

NEW APPLICATION ENTERED

CTX310

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by CRISPR Therapeutics AG

Other Marks by Tiffany D. Gehrke

Resources

Company